FDA Expands Indications for Pifeltro and Delstrigo for HIV FDA Expands Indications for Pifeltro and Delstrigo for HIV

The FDA expanded the indications for the two HIV drugs to include appropriate patients with HIV-1 with virological suppression.FDA Approvals

Source: Medscape Pharmacist Headlines - September 20, 2019 Category: Drugs & Pharmacology Tags: HIV/AIDS News Alert Source Type: news